Here's What You May Have Missed About Gilead Sciences (GILD)

Gilead Sciences logged a -0.7% change during today's evening session, and is now trading at a price of $80.61 per share. On average, analysts give it a target price of $85.47.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The large-cap company is based in the United States. Gilead Sciences currently returns an annual dividend yield of 3.6%.

Make Sure to Consider the Following Before Buying Gilead Sciences:

  • Gilead Sciences has moved -0.0% over the last year.

  • GILD has a forward P/E ratio of 11.8 based on its EPS guidance of 6.82.

  • Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 0.7%.

  • The company has a price to earnings growth (PEG) ratio of 3.05.

  • Its Price to Book (P/B) ratio is 4.75

Gilead Sciences Has None

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 9,512,000 586,000 8,926,000 6.98
2022 9,072,000 728,000 8,344,000 -22.78
2021 11,384,000 579,000 10,805,000 43.72
2020 8,168,000 650,000 7,518,000 -9.63
2019 9,144,000 825,000 8,319,000 11.28
2018 8,400,000 924,000 7,476,000


The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.